Acurx Pharmaceuticals Inc
NASDAQ:ACXP

Watchlist Manager
Acurx Pharmaceuticals Inc Logo
Acurx Pharmaceuticals Inc
NASDAQ:ACXP
Watchlist
Price: 0.348 USD -7.74% Market Closed
Market Cap: 8.2m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
-3%
Net Income
Forecast
+7%

Wall Street
Price Targets

ACXP Price Targets Summary
Acurx Pharmaceuticals Inc

There are no price targets for ACXP.
ACXP Lowest Forecast
Wall Street Target
Not Available
ACXP Average Forecast
Wall Street Target
Not Available
ACXP Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Acurx Pharmaceuticals Inc Competitors:
Price Targets
BSLN
Basilea Pharmaceutica AG
93% Upside
FYB
Formycon AG
107% Upside
ALT
Altimmune Inc
311% Upside
301080
Acrobiosystems Co Ltd
10% Upside
BSLN
Basilea Pharmaceutica AG
93% Upside
FYB
Formycon AG
107% Upside
ALT
Altimmune Inc
311% Upside
301080
Acrobiosystems Co Ltd
10% Upside
ASND
Ascendis Pharma A/S
30% Upside
C
2487
Cutia Therapeutics
14% Upside
BMRN
Biomarin Pharmaceutical Inc
72% Upside
ADMA
ADMA Biologics Inc
47% Upside

Revenue
Forecast

Revenue Estimate
Acurx Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Acurx Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Acurx Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
What are analyst estimates?

See Also

Summary
ACXP intrinsic value, competitors valuation, and company profile.
DCF Valuation
ACXP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ACXP stock valuation using valuation multiples.
Wall Street Estimates
ACXP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ACXP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACXP's stock price target?
Not Available

ACXP doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.